Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


20.02.2017

2 Acta Haematol
2 Am J Hematol
1 Biochem Biophys Res Commun
2 BMC Cancer
1 Cancer
1 Cancer Res
3 Eur J Haematol
1 Genes Chromosomes Cancer
2 Int J Hematol
1 Leuk Lymphoma
1 Leuk Res
3 Leukemia
1 Oncogene
2 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Haematol

  1. QUINTELA A, Sujobert P, Callet-Bauchu E, Salles G, et al
    Ibrutinib-Induced Lymphocytosis: Cytological Features.
    Acta Haematol. 2017;137:55-57.
    PubMed     Text format    

  2. LONGU F, Fozza C, Dessi L, Longinotti M, et al
    Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.
    Acta Haematol. 2017;137:15-16.
    PubMed     Text format    


    Am J Hematol

  3. HU Z, Medeiros LJ, Fang L, Sun Y, et al
    Prognostic Significance of Cytogenetic Abnormalities in T-Cell Prolymphocytic Leukemia.
    Am J Hematol. 2017 Feb 14. doi: 10.1002/ajh.24679.
    PubMed     Text format     Abstract available

  4. USTUN C, Williams S, Skendzel S, Kodal B, et al
    Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia.
    Am J Hematol. 2017 Feb 10. doi: 10.1002/ajh.24673.
    PubMed     Text format    


    Biochem Biophys Res Commun

  5. SHIMOSAKI S, Nakahata S, Ichikawa T, Kitanaka A, et al
    Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
    Biochem Biophys Res Commun. 2017 Feb 8. pii: S0006-291X(17)30307.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. BARBOSA-CORTES L, Lopez-Alarcon M, Mejia-Arangure JM, Klunder-Klunder M, et al
    Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country.
    BMC Cancer. 2017;17:125.
    PubMed     Text format     Abstract available

  7. CHOW YP, Alias H, Jamal R
    Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
    BMC Cancer. 2017;17:120.
    PubMed     Text format     Abstract available


    Cancer

  8. LAUSEKER M, Hasford J, Saussele S, Kremers S, et al
    Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death.
    Cancer. 2017 Feb 13. doi: 10.1002/cncr.30636.
    PubMed     Text format     Abstract available


    Cancer Res

  9. DE SMITH AJ, Kaur M, Gonseth S, Endicott AA, et al
    Correlates of prenatal and early-life tobacco smoke exposure and frequency of common gene deletions in childhood acute lymphoblastic leukemia.
    Cancer Res. 2017 Feb 15. pii: canres.2571.2016.
    PubMed     Text format     Abstract available


    Eur J Haematol

  10. DEGWERT N, Latuske E, Vohwinkel G, Stamm H, et al
    Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Eur J Haematol. 2016;97:239-44.
    PubMed     Text format     Abstract available

  11. KRISTENSEN L, Kristensen T, Abildgaard N, Royo C, et al
    LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
    Eur J Haematol. 2016;97:175-82.
    PubMed     Text format     Abstract available

  12. THIELEN N, Visser O, Ossenkoppele G, Janssen J, et al
    Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012.
    Eur J Haematol. 2016;97:145-54.
    PubMed     Text format     Abstract available


    Genes Chromosomes Cancer

  13. GOLDBERG L, Gough SM, Lee F, Dang C, et al
    Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance.
    Genes Chromosomes Cancer. 2017 Feb 14. doi: 10.1002/gcc.22451.
    PubMed     Text format     Abstract available


    Int J Hematol

  14. IWASA M, Miura Y, Fujishiro A, Fujii S, et al
    Erratum to: Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Int J Hematol. 2017 Feb 9. doi: 10.1007/s12185-017-2182.
    PubMed     Text format    

  15. SHIGEMATSU A, Kako S, Mitsuhashi K, Iwato K, et al
    Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Int J Hematol. 2017 Feb 14. doi: 10.1007/s12185-017-2197.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  16. BUTLER JS, Qiu YH, Zhang N, Yoo SY, et al
    Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.
    Leuk Lymphoma. 2017;58:1207-1218.
    PubMed     Text format     Abstract available


    Leuk Res

  17. YAO J, Zhang G, Liang C, Li G, et al
    Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary acute myeloid leukemia in first remission.
    Leuk Res. 2017;55:97-104.
    PubMed     Text format     Abstract available


    Leukemia

  18. RATNAPARKHE M, Hlevnjak M, Kolb T, Jauch A, et al
    Genomic profiling of acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.
    Leukemia. 2017 Feb 15. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  19. KOBAYASHI S, Kobayashi A, Osawa Y, Nagao S, et al
    Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation.
    Leukemia. 2017 Feb 14. doi: 10.1038/leu.2017.
    PubMed     Text format    

  20. ETXABE A, Lara-Castillo MC, Cornet-Masana JM, Banus-Mulet A, et al
    Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem-cell functionality: A promising novel therapeutic target.
    Leukemia. 2017 Feb 14. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    Oncogene

  21. VAN ATTEKUM MH, Terpstra S, Slinger E, von Lindern M, et al
    Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    Oncol Rep

  22. LYU X, Li J, Yun X, Huang R, et al
    miR-181a-5p, an inducer of Wnt-signaling, facilitates cell proliferation in acute lymphoblastic leukemia.
    Oncol Rep. 2017;37:1469-1476.
    PubMed     Text format     Abstract available

  23. TAO YF, Li ZH, Du WW, Xu LX, et al
    Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.
    Oncol Rep. 2017;37:1419-1429.
    PubMed     Text format     Abstract available


    PLoS One

  24. STEFANKO A, Thiede C, Ehninger G, Simons K, et al
    Lipidomic approach for stratification of acute myeloid leukemia patients.
    PLoS One. 2017;12:e0168781.
    PubMed     Text format     Abstract available

  25. MINAGAWA K, Jamil MO, Al-Obaidi M, Pereboeva L, et al
    Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.
    PLoS One. 2017;12:e0172640.
    PubMed     Text format     Abstract available

  26. KO PS, Liu YC, Yeh CM, Gau JP, et al
    The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification.
    PLoS One. 2017;12:e0172029.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: